Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 7 studies | 34% ± 12% | |
| glutamatergic neuron | 7 studies | 48% ± 19% | |
| neuron | 6 studies | 27% ± 10% | |
| mast cell | 6 studies | 22% ± 5% | |
| astrocyte | 6 studies | 34% ± 16% | |
| oligodendrocyte | 6 studies | 28% ± 8% | |
| interneuron | 5 studies | 42% ± 25% | |
| oligodendrocyte precursor cell | 5 studies | 31% ± 13% | |
| GABAergic neuron | 5 studies | 44% ± 17% | |
| retinal ganglion cell | 4 studies | 50% ± 19% | |
| epithelial cell | 4 studies | 22% ± 5% | |
| pericyte | 4 studies | 24% ± 5% | |
| granule cell | 3 studies | 26% ± 11% | |
| macrophage | 3 studies | 21% ± 6% | |
| microglial cell | 3 studies | 24% ± 6% | |
| adipocyte | 3 studies | 18% ± 3% | |
| OFF-bipolar cell | 3 studies | 28% ± 6% | |
| fibroblast | 3 studies | 22% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 10 studies | 34% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 7696.77 | 2642 / 2642 | 100% | 29.00 | 705 / 705 |
| thymus | 100% | 4378.13 | 653 / 653 | 100% | 27.47 | 604 / 605 |
| ovary | 100% | 3422.84 | 180 / 180 | 100% | 20.76 | 429 / 430 |
| kidney | 100% | 3387.57 | 89 / 89 | 99% | 22.30 | 896 / 901 |
| prostate | 100% | 3739.45 | 244 / 245 | 100% | 16.94 | 501 / 502 |
| breast | 100% | 4635.51 | 459 / 459 | 99% | 20.27 | 1109 / 1118 |
| adrenal gland | 99% | 2439.94 | 256 / 258 | 100% | 25.17 | 229 / 230 |
| intestine | 100% | 3911.95 | 966 / 966 | 98% | 13.75 | 518 / 527 |
| uterus | 100% | 4267.56 | 170 / 170 | 98% | 15.19 | 448 / 459 |
| esophagus | 99% | 3760.38 | 1433 / 1445 | 98% | 15.92 | 180 / 183 |
| lung | 100% | 3747.13 | 576 / 578 | 98% | 15.99 | 1129 / 1155 |
| liver | 98% | 1837.65 | 222 / 226 | 98% | 12.33 | 399 / 406 |
| stomach | 97% | 2637.05 | 350 / 359 | 99% | 14.76 | 283 / 286 |
| bladder | 100% | 3460.90 | 21 / 21 | 95% | 14.42 | 480 / 504 |
| skin | 93% | 1909.93 | 1690 / 1809 | 99% | 18.33 | 467 / 472 |
| pancreas | 85% | 1166.38 | 278 / 328 | 99% | 18.30 | 176 / 178 |
| adipose | 100% | 5176.57 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 16.34 | 80 / 80 |
| spleen | 100% | 2669.60 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 11.16 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 17.76 | 1 / 1 |
| blood vessel | 100% | 5393.45 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 3783.53 | 802 / 803 | 0% | 0 | 0 / 0 |
| heart | 100% | 4015.42 | 858 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 10.36 | 27 / 29 |
| peripheral blood | 58% | 768.08 | 539 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0050688 | Biological process | regulation of defense response to virus |
| GO_0045087 | Biological process | innate immune response |
| GO_0005814 | Cellular component | centriole |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0005813 | Cellular component | centrosome |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CCDC92 |
| Protein name | Coiled-coil domain-containing protein 92 (Limkain beta-2) Coiled-coil domain containing 92 Coiled-coil domain containing 92 (Coiled-coil domain-containing protein 92) Coiled-coil domain-containing protein 92 |
| Synonyms | |
| Description | FUNCTION: Interferon-stimulated protein that plays a role in innate immunity. Strongly inhibits ebolavirus transcription and replication. Forms a complex with viral RNA-bound nucleocapsid NP and thereby prevents the transport of NP to the cell surface. . |
| Accessions | F5GXK2 F5H2Z7 ENST00000632401.1 [Q53HC0-1] ENST00000539551.5 F5H7P8 ENST00000631954.1 ENST00000535556.5 ENST00000633097.1 ENST00000539761.5 ENST00000545135.5 [Q53HC0-2] ENST00000631749.1 [Q53HC0-2] ENST00000633908.1 ENST00000614047.2 [Q53HC0-2] A0A0J9YWX2 F5H285 ENST00000545891.5 [Q53HC0-2] Q53HC0 ENST00000633868.1 ENST00000238156.8 [Q53HC0-1] ENST00000545037.1 |